XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 154 filers reported holding XENON PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 1.16 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $718,100 | -12.7% | 21,500 | 0.0% | 0.15% | -18.7% |
Q2 2023 | $822,375 | -3.0% | 21,500 | 0.0% | 0.18% | -43.3% |
Q4 2022 | $847,745 | +9.0% | 21,500 | 0.0% | 0.32% | +68.1% |
Q3 2022 | $778,000 | +3.2% | 21,500 | -12.2% | 0.19% | +15.8% |
Q2 2022 | $754,000 | -2.2% | 24,500 | 0.0% | 0.16% | +24.1% |
Q4 2021 | $771,000 | +0.1% | 24,500 | 0.0% | 0.13% | -5.0% |
Q3 2021 | $770,000 | +69.2% | 24,500 | 0.0% | 0.14% | +59.1% |
Q2 2021 | $455,000 | +5.3% | 24,500 | 0.0% | 0.09% | -3.3% |
Q1 2021 | $432,000 | +15.5% | 24,500 | 0.0% | 0.09% | +7.1% |
Q4 2020 | $374,000 | +29.9% | 24,500 | 0.0% | 0.08% | +9.0% |
Q3 2020 | $288,000 | – | 24,500 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ghost Tree Capital, LLC | 850,000 | $15,215,000 | 3.58% |
ACUTA CAPITAL PARTNERS, LLC | 412,500 | $7,384,000 | 2.66% |
BVF INC/IL | 3,481,778 | $62,324,000 | 2.34% |
Soleus Capital Management, L.P. | 708,117 | $12,675,000 | 2.28% |
COMMODORE CAPITAL LP | 301,392 | $5,395,000 | 2.15% |
DAFNA Capital Management LLC | 406,535 | $7,277,000 | 1.73% |
Parkman Healthcare Partners LLC | 374,395 | $6,702,000 | 1.56% |
Avoro Capital Advisors LLC | 3,650,000 | $65,335,000 | 1.13% |
KNOTT DAVID M | 144,101 | $2,579,000 | 1.10% |
Orbimed Advisors | 2,497,917 | $44,713,000 | 0.42% |